ClinicalTrialsFinder
RecruitingNot ApplicableNCT05024344

ESP Block vs Control for Pain Control Following Percutaneous Nephrolithotomy

Erector Spinae Plane Block Versus Control for Pain Control Following Percutaneous Nephrolithotomy: A Randomized, Double-Blind, Placebo Controlled Study

Sponsor

University of Tennessee Medical Center

Enrollment

128 participants

Start Date

Aug 9, 2021

Study Type

INTERVENTIONAL

Conditions

Nephrolithotomy, Percutaneous

Summary

The purpose of this study is to investigate the use of the erector spinae (ESP) block in reducing the morphine milligram equivalent (MME) consumption post percutaneous nephrolithotomy. Objectives: 1. \- Determine if there is a significant effect on post percutaneous nephrolithotomy MME consumption with the usage of an ESP block vs. saline control. 2. \- Determine if there is a significant effect on reported pain levels with the use of an ESP block vs. saline control in post percutaneous nephrolithotomies.

Eligibility

Min Age: 18 Years

Inclusion Criteria5

  • Adults, male and female greater than or equal to 18 years of age and undergoing non-emergent percutaneous nephrolithotomy Monday through Friday between the hours of 6:00AM and 4:00PM.
  • Female participants of childbearing potential will be required to provide a negative pregnancy test.
  • Ability to understand and teach back consent for the procedure.
  • Willingness to sign consent for procedure.
  • English speaking.

Exclusion Criteria9

  • Emergent surgery status.
  • Local infection
  • Allergy to local anesthetics.
  • Recreational drug use.
  • Inability to provide informed consent.
  • Pregnancy or breastfeeding.
  • History of Guillain-Barre' Syndrome.
  • Underlying medical conditions that would post a significant risk to the patient.
  • Opioid use >90 days in the year leading up to surgery.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

PROCEDUREErector Spinae Plane Block

The Anesthesiologist will use ultrasound-guided technique and inject 30mL of 0.5% ropivacaine with 4 mg of dexamethasone or saline placebo control into the erector spinae muscle, superficial to the tips of the thoracic transverse processes

DRUGRopivacaine 0.5% Injectable Solution

The Anesthesiologist will use ultrasound-guided technique and inject 30mL of 0.5% ropivacaine with 4 mg of dexamethasone or saline placebo control into the erector spinae muscle, superficial to the tips of the thoracic transverse processes

DRUGDexamethasone

The Anesthesiologist will use ultrasound-guided technique and inject 30mL of 0.5% ropivacaine with 4 mg of dexamethasone or saline placebo control into the erector spinae muscle, superficial to the tips of the thoracic transverse processes

Locations(1)

University of Tennessee Medical Center

Knoxville, Tennessee, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05024344